FDA Letter API

Sunny Creek Farm Inc.

Letter data

Company
Sunny Creek Farm Inc.
Recipient
Lee G. Ewing | President and Owner | Sunny Creek Farm Inc. | 520 Pinefield Drive | Tryon | , | NC | 28782-7795 | United States | Lee.Ewing@sunnycreekfarm.com
Issue date
2022-12-08
Posted date
Not available
FDA office
Division of Human and Animal Food Operations East III
Subject
Not available
Product
Food & Beverages
CMS ID
617664
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Sunny Creek Farm Inc. MARCS-CMS 617664 — December 08, 2022 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: Via Email Product: Food & Beverages Recipient: Recipient Name Lee G. Ewing Recipient Title President and Owner Sunny Creek Farm Inc. 520 Pinefield Drive Tryon , NC 28782-7795 United States Lee.Ewing@sunnycreekfarm.com Issuing Office: Division of Human and Animal Food Operations East III United States Dear Mr. Ewing: The Food and Drug Administration has completed evaluation of your firm’s corrective actions in response to our Warning Letter 617664 dated February 2, 2022. We also verified your actions during an FDA inspection that ended September 15, 2022. Based on our evaluation and inspection, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. For questions about this letter, please contact: Stephen J. Rabe, Compliance Officer at: orahafeast3firmresponses@fda.hhs.gov and Stephen.rabe@fda.hhs.gov or by telephone at: 513-322-0660: Sincerely, /S/ Stephen J. Rabe Compliance Officer Content current as of: 12/12/2022 Regulated Product(s) Food & Beverages